Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

Approved Antiretroviral Drugs

From San Francisco AIDS Foundation

Winter 2005/2006

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Generic (Common) Name Brand Name Company Year Approved
Protease Inhibitors (PIs)
amprenavir Agenerase GlaxoSmithKline 1999; discontinued 2004
atazanavir Reyataz Bristol-Myers Squibb 2003
fosamprenavir Lexiva (U.S.); Telzir (Europe) GlaxoSmithKline 2003
indinavir Crixivan Merck 1996
lopinavir/ritonavir Kaletra Abbott 2000; Meltrex formulation 2005
nelfinavir Viracept Pfizer 1997
ritonavir Norvir Abbott 1996
saquinavir Invirase (hard-gel)
Fortovase (soft-gel)		 Roche 1995
1997; withdrawn 2005
tipranavir Aptivus Boehringer Ingelheim 2005
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
abacavir Ziagen GlaxoSmithKline 1998
didanosine (ddI) Videx Bristol-Myers Squibb 1989; extended release Videx EC 2000
emtricitabine (FTC) Emtriva Gilead 2003
lamivudine (3TC) Epivir GlaxoSmithKline 1995
stavudine (d4T) Zerit Bristol-Myers Squibb 1994
zalcitabine (ddC) Hivid Roche 1992; withdrawn 2005
zidovudine (AZT) Retrovir GlaxoSmithKline 1987
tenofovir DF Viread Gilead 2002
NRTI Fixed-Dose Combinations
zidovudine/lamivudine Combivir GlaxoSmithKline 1997
zidovudine/lamivudine/abacavir Trizivir GlaxoSmithKline 2000
lamivudine/abacavir Epzicom (U.S.); Kivexa (Europe) GlaxoSmithKline 2004
tenofovir/emtricitabine Truvada Gilead 2004
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdine Rescriptor Pfizer 1997
efavirenz Sustiva (U.S.); Stocrin (elsewhere) Bristol-Myers Squibb 1998
nevirapine Viramune Boehringer Ingelheim 1996
Entry/Fusion Inhibitors
enfuvirtide (T-20) Fuzeon Trimeris 2003


A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF
This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. Visit San Francisco AIDS Foundation's Web site to find out more about their activities, publications and services.
 
See Also
HIV Medications: When to Start and What to Take -- A Guide From TheBody.com
More on HIV Medications

 

Advertisement